解涛, 高谦, 郭雪园, 戈含笑, 于丽伟. 骶管注射治疗腰椎间盘突出症的疗效评价[J]. 解放军医学院学报, 2015, 36(4): 322-325. DOI: 10.3969/j.issn.2095-5227.2015.04.006
引用本文: 解涛, 高谦, 郭雪园, 戈含笑, 于丽伟. 骶管注射治疗腰椎间盘突出症的疗效评价[J]. 解放军医学院学报, 2015, 36(4): 322-325. DOI: 10.3969/j.issn.2095-5227.2015.04.006
XIE Tao, GAO Qian, GUO Xueyuan, GE Hanxiao, YU Liwei. Effect of sacral canal injection therapy on patients with lumbar intervertebral disc protrusion[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(4): 322-325. DOI: 10.3969/j.issn.2095-5227.2015.04.006
Citation: XIE Tao, GAO Qian, GUO Xueyuan, GE Hanxiao, YU Liwei. Effect of sacral canal injection therapy on patients with lumbar intervertebral disc protrusion[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2015, 36(4): 322-325. DOI: 10.3969/j.issn.2095-5227.2015.04.006

骶管注射治疗腰椎间盘突出症的疗效评价

Effect of sacral canal injection therapy on patients with lumbar intervertebral disc protrusion

  • 摘要: 目的 探讨骶管注射治疗腰椎间盘突出症的疗效。 方法 随机抽取2012年8月-2014年8月于解放军总医院康复医学中心接受治疗的腰椎间盘突出症患者200例,100例骶管注射治疗,100例牵引治疗作为对照,比较骶管注射治疗和牵引治疗后3 d、7 d、14 d、21 d患者视觉模拟评分(visual analogue scale,VAS)和直腿抬高数的变化及效果。 结果 骶管注射组治愈58例,腰椎牵引组治愈患者40例,两组差异有统计学意义(P< 0.05)。骶管注射治疗和腰椎牵引治疗前VAS评分为7.11和7.28,治疗后21 d VAS评分为1.13和2.01,明显低于治疗前(P< 0.01)。骶管注射治疗和腰椎牵引治疗后直腿抬高试验指数为70.83和64.43,明显高于治疗前的34.21和36.22(P< 0.01)。骶管注射治疗后3 d和腰椎牵引治疗后3 d其直腿抬高试验指数分别为41.87和41.66(P> 0.05);骶管注射治疗后7 d、14 d、21 d直腿抬高试验平均指数分别为54.11、60.32、70.83,高于腰椎牵引治疗后的50.21、58.78、64.43(P< 0.05)。 结论 骶管注射治疗可减轻患者疼痛和提高直腿抬高试验数值,并且长期疗效好于短期疗效。

     

    Abstract: Objective To evaluate the therapeutic effect of sacral canal injection therapy on patients with lumbar intervertebral disc protrusion. Methods Two hundred patients with lumbar intervertebral disc protrusion were included and they were divided into two groups:patients undergoing lumber traction treatment group (n=100) and patients undergoing sacral canal injection therapy group (n=100). The scores of VAS and Straight-leg raising test of 3 d, 7 d, 14 d, 21 d after lumber traction treatment and sacral canal injection therapy were compared in each group. Results The effective rate of patients with sacral canal injection therapy (58/100) was higher than that of patients with lumber traction therapy (40/100) with significant difference (P< 0.05). The VAS score of patients with sacral canal injection therapy (7.11) was lower than that of patients with lumber traction therapy (7.28), after the treatment for 21 days, the VAS score were 1.13 and 2.01, respectively, which were significantly lower than before treatment (P< 0.01); The score of straight-leg raising test of patients with sacral canal injection therapy (70.83) was higher than that of patients with lumber traction therapy (64.43), which were significantly higher than before treatment (34.21 vs. 36.22, P< 0.01). The scores of straight-leg raising test of 3 d after sacral canal injection therapy and lumber traction therapy were 41.87 and 41.66, which was of no significant difference (P> 0.05). And the scores of straight-leg raising test of 7 d, 14 d and 21 d after sacral canal injection therapy and lumber traction therapy were 54.11, 60.32, 70.83 and 50.21, 58.78, 64.43, respectively, which was of significant difference (P< 0.05). Conclusion Sacral canal injection therapy has therapeutic effect on patients with lumbar intervertebral disc protrusion. The sacral canal injection therapy can decrease VAS score and improve the performance in straight-leg raising test.

     

/

返回文章
返回